Single-use bioreactor technology offers a set of benefits compared to common glass or stainless-steel vessels, including reduced downtime between runs, minimal cleaning effort, or decreased cross-contamination risk. In that regard, BioBLU® Single-Use Bioreactors combine the benefits of single-use bioreactor technology with the reliable performance of conventional glass or stainless-steel bioreactors. Furthermore, using them together with a powerful bioprocess controller like the BioFlo® 320 enables precise cell culture parameter control and seamless process transition to up to 40 L of working volume.
CRISPR screen highlights genes behind T cell plasticity in autoimmunity
Latest NewsResearchers at University Hospital Hamburg-Eppendorf have laid the foundation to screen for molecules that shift Th17 cells from proinflammatory or immune-dampening mode.
GSK closes US$50m acquisition with Elsie Biotechnologies Inc
Latest NewsGSK takes over Elsie Biotechnologies in US$50m deal to boost its oligonucleotide-based drug platform and pipeline.
ITM gets equity to launch Phase III lead radiopharmaceutical ITM-11
Latest NewsITM Isotope Technologies Munich SE has raised €188m ito boost radiopharma pipeline, contract manufacturing cpacity, and launch ITM-11.
Quantro Therapeutics cashes in milestone payment from Boehringer Ingelheim
Latest NewsViennese biotech QUANTRO Therapeutics identifies small molecule targeting an onkogenic transcription factor in Boehringer Ingelheim collab.
Young biotech company recruits experienced CMO
AppointmentsAt the end of May, Dr Uwe Meya took over as Chief Medical Officer at Oxford-based SynaptixBio.
DefiniGEN and Atelerix prevent freezing damage in cell models
Latest NewsDefiniGEN Ltd., and Atelerix Ltd. have successfully shipped in vitro liver models from the UK to the US without freezing them thus preventing cell damage and loss-of function.
The Renewable Materials Conference Hits the Mark Again
Sponsored Publications440 participants discussed the defossilisation of the chemical and materials industry through biomass, CO2 and recycling. The audience voted for the “Renewable Material of the Year 2024”: Acetic acid from CO2 by Danish start-up Again wins 1st price.
Wacker Chemie AG opens €100m RNA manufacturing site
Latest NewsWith the opening of a production centRE for RNA vaccines and therapeutics, German CDMO Wacker Biotech is expanding its expertise in the field of RNA active ingredients.
IZB Start-up mk2
Sponsored PublicationsMk2 Biotechnologies GmbH was founded in 2020 and is located in the Innovation and Start-up Centre IZB in Planegg-Martinsried.
BioBLU® Single-Use Bioreactors and BioFlo® 320 bioprocess controller – Single-Use Simplicity Under Control
ProductsSingle-use bioreactor technology offers a set of benefits compared to common glass or stainless-steel vessels, including reduced downtime between runs, minimal cleaning effort, or decreased cross-contamination risk. In that regard, BioBLU® Single-Use Bioreactors combine the benefits of single-use bioreactor technology with the reliable performance of conventional glass or stainless-steel bioreactors. Furthermore, using them together with a powerful bioprocess controller like the BioFlo® 320 enables precise cell culture parameter control and seamless process transition to up to 40 L of working volume.